SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 1 — Billie Holiday

PatientBillie Holiday
Date of birth1993-04-07
IdentifiersMRN HR-ML010-SYN; SSN (made up) 000-10-4472
Document date2026-04-20
AuthorConstance Mayfield, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Subjective

The patient attends this visit for establishing primary care five weeks after release from custody: medication for opioid use disorder, overdose prevention, alcohol care, liver and infection screening, and depression and safety screening. [S]

Objective

Hemoglobin: 12.4 g/dL; MCV: 101 fL (high); Platelets: 236 10*3/uL; Sodium: 138 mmol/L; Potassium: 4 mmol/L; Creatinine: 0.72 mg/dL; eGFR: 113 mL/min/1.73 m²; Glucose: 88 mg/dL; AST: 52 U/L (high); ALT: 38 U/L; GGT: 84 U/L (high); Albumin: 4 g/dL; Total bilirubin: 0.7 mg/dL; Hepatitis C antibody (signal-to-cutoff): 0.09; Hepatitis B surface antibody: 3 m[IU]/mL (low); Phosphatidylethanol (PEth): 312 ng/mL (high); PHQ-9: 9; AUDIT-C: 8; DAST-10: 7. [S]

Vital Signs

DateMeasureValueUnitProvenance
2026-04-20Body height165cmS
2026-04-20Body weight68kgS
2026-04-20Body mass index (BMI) [Ratio]25kg/m2S
2026-04-20Systolic blood pressure126mm[Hg]S
2026-04-20Diastolic blood pressure80mm[Hg]S
2026-04-20Heart rate84/minS
2026-04-20Respiratory rate16/minS
2026-04-20Body temperature36.8CelS
2026-04-20Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-04-20Hemoglobin [Mass/volume] in Blood12.4g/dL11.6-15 g/dLNormalS
2026-04-20MCV [Entitic mean volume] in Red Blood Cells by Automated count101fL80-100 fLHighS
2026-04-20Platelets [#/volume] in Blood by Automated count23610*3/uL150-400 10*3/uLNormalS
2026-04-20Sodium [Moles/volume] in Serum or Plasma138mmol/L135-145 mmol/LNormalS
2026-04-20Potassium [Moles/volume] in Serum or Plasma4mmol/L3.5-5.1 mmol/LNormalS
2026-04-20Creatinine [Mass/volume] in Serum or Plasma0.72mg/dL0.59-1.04 mg/dLNormalS
2026-04-20Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M113mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-04-20Glucose [Mass/volume] in Serum or Plasma88mg/dL70-99 mg/dLNormalS
2026-04-20Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma52U/L10-40 U/LHighS
2026-04-20Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma38U/L7-56 U/LNormalS
2026-04-20Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma84U/L5-40 U/LHighS
2026-04-20Albumin [Mass/volume] in Serum or Plasma4g/dL3.5-5 g/dLNormalS
2026-04-20Bilirubin.total [Mass/volume] in Serum or Plasma0.7mg/dL0.1-1.2 mg/dLNormalS
2026-04-20Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay0.09{s_co_ratio}Below 1.00 is nonreactiveNormalS
2026-04-20Hepatitis B virus surface Ab [Units/volume] in Serum3m[IU]/mL>=10 m[IU]/mLLowS
2026-04-20Phosphatidylethanol [Mass/volume] in Blood312ng/mLBelow 20 ng/mL: abstinence or light drinking; 20 to 199: significant drinking; 200 or more: heavy drinkingHighS
2026-04-20Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]9{score}S
2026-04-20Total score [AUDIT-C]8{score}S
2026-04-20Total score [DAST-10]7{score}S

Medications

MedicationFrequencyRouteDatesStatusEvidence
Buprenorphine 8 mg and naloxone 2 mg sublingual film: half a film (4 mg) on day 1, then one film (8 mg) under the tongue dailyOne film under the tongue daily after a 4 mg first doseSublingual route2026-04-20 to 2026-04-27completedS
Naloxone 4 mg nasal spray, one spray in one nostril for a suspected opioid overdose; may repeat every 2 to 3 minutes in alternating nostrils; call 911One spray (4 mg) in one nostril for suspected overdose; repeat every 2 to 3 minutes if there is no responseNasal route2026-04-20activeS
Thiamine 100 mg oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route2026-04-20 to 2026-10-19completedS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Problems

ProblemClinical statusVerificationCodeProvenance
Opioid use disorder (heroin), severe; in early remission in a controlled environment at intake, five weeks after release from custody; on buprenorphine; synthetic modern episode linked to her documented heroin useactiveconfirmed F11.20S — Synthetic modern coding of the documented heroin addiction; language is person-first, and the code does not change with a return to use.
Alcohol use disorder, moderate; synthetic modern episode linked to her documented heavier drinking after her mother's deathactiveconfirmed F10.20S — Synthetic modern coding of the documented drinking; the liver disease reported in her last year is not coded, because it was documented long after the episode.

Assessment

Plan of Treatment